Related Experiment Videos
Surgical complications of amyloid disease
D P O'Doherty1, J P Neoptolemos, D C Bouch
1Department of Surgery, Leicester Royal Infirmary, UK.
Postgraduate Medical Journal
|April 1, 1987
Abstract:
The case of a man with primary systemic amyloidosis without myelomatosis and long-term survival is described. The patient has had major surgical complications from large amyloid deposits in the colon, dorsal spine and peritoneal cavity. The patient remains well 14 years after diagnosis.
Insights
This case study highlights long-term survival in a patient with primary systemic amyloidosis. Despite significant surgical complications from amyloid deposits, the patient maintained good health for 14 years post-diagnosis.
Area of Science:
- Medicine
- Oncology
- Gastroenterology
Background:
- Primary systemic amyloidosis is a rare plasma cell disorder.
- It typically involves the deposition of amyloid fibrils in various organs, leading to organ dysfunction.
- Myelomatosis is a common comorbidity, but this case presents without it.
Observation:
- A male patient diagnosed with primary systemic amyloidosis.
- The patient experienced severe surgical complications due to extensive amyloid deposits in the colon, dorsal spine, and peritoneal cavity.
- The patient's condition was managed, and they remained well for an extended period.
Findings:
- The patient achieved long-term survival, remaining well 14 years after the initial diagnosis.
- This case demonstrates a rare instance of prolonged survival in primary systemic amyloidosis without myelomatosis, despite major surgical challenges.
- Successful management of surgical complications was crucial for the patient's outcome.
Implications:
- This case suggests that long-term survival is possible in select primary systemic amyloidosis patients, even with extensive organ involvement and surgical complications.
- It underscores the importance of comprehensive management strategies for amyloidosis patients.
- Further research into factors contributing to long-term survival in amyloidosis could improve patient care and treatment protocols.